Skip to content

Invesco S&P 500 Equal Weight Health Care ETF

RSPHNYSE ArcaB

$37.76−0.14 (−0.37%)

At close: Oct 13, 2026, 4:00 PM

Intraday session: down, 77 prints from 37.90 to 37.76. Range 37.53 to 38.09. Use the arrow keys to read each point.37.6038.0038.1010 AM12 PM2 PM4 PM
Expense ratio
0.40%
Fund size
$890M
1Y total return
+29.1%
Yield · Last 12 months
0.59%
Holdings
62
Avg volume · 30D
0.2M sh
NAV per share
$37.60
52W range
low $29.46high $38.19
Launched

The ETF.net RSPH Grade

B

Score 68 out of 100

Rank
6 of 25
Six-pillar profile for RSPH. Scores out of 100: Cost 58, Risk 78, Mission 77, Tradability 66, Holdings 88, Durability 68. Strongest: Holdings (88). Weakest: Cost (58). Leans toward Holdings.

Score 68 of 100 falls in the B band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    B58 out of 100
    Rank 11 of 25
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    A77 out of 100
    Rank 4 of 11
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    A78 out of 100
    Rank 4 of 24
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    B66 out of 100
    Rank 7 of 25
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    A88 out of 100
    Rank 2 of 25
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    B68 out of 100
    Rank 10 of 25

Our read on RSPH

ETF.net Research

BHealth care without the mega-cap gravity: RSPH gives every health care name in the S&P 500 the same slice, so no single drug giant steers the fund. It has been running that way since 2006.

Stated mandate

The Fund seeks to track the investment results of the S&P 500 Equal Weight Health Care Index.

Why people hold it

  1. 01Equal weighting by design: about 60 S&P 500 health care names, each with the same slice, so one blockbuster drugmaker doesn't set the tone for the basket.
  2. 02Charges 0.40% a year, below the 0.50% typical of broad health care ETFs.
  3. 03Live since 2006, through drug-pricing fights, patent cliffs and a pandemic, and rated one of the stronger builds in its health care peer group.
  4. 04Spread is the point: the portfolio is one of the best-diversified in the cohort, with weight split across the sector rather than parked in a few giants.

Worth knowing

  1. 01The big cap-weighted rivals cost far less: XLV and FHLC charge 0.08%, VHT 0.09%. You're paying up for the equal-weight tilt.
  2. 02Equal weight leans toward the sector's smaller members, so results can drift from cap-weighted health care funds in either direction.
  3. 03One sector, one set of risks: policy shifts, pricing rules and patent cycles move the whole basket at once.

RSPH Holdings

As of Oct 12, 2026
Asset class
Stocks
Holdings
62
Top-10 weight
20%
Largest holding
MRNA2.7%

Sectors

  • Health Care98.2%
  • Technology1.8%
  • Financials0.0%

Geography

  • United States96.88%
  • Ireland3.12%
The fund’s holdings, weight-ordered — page 1 of 5.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001MRNAModerna Inc2.67%105,588$24M286
002ILMNIllumina Inc2.18%69,859$19M322
003PKIRevvity Inc2.00%115,587$18M71
004MTDMettler-Toledo International Inc1.93%11,102$17M273
005ISRGIntuitive Surgical Inc1.93%40,532$17M410
006AAgilent Technologies Inc1.90%98,932$17M317
007VEEVVeeva Systems Inc1.83%54,929$16M323
008ABBVAbbVie Inc1.77%57,070$16M522
009TMOThermo Fisher Scientific Inc1.75%23,642$16M375
010WSTWest Pharmaceutical Services Inc1.75%42,502$16M284
011CRLCharles River Laboratories International Inc1.74%51,402$16M216
012HUMHumana Inc1.73%35,756$15M309
013DHRDanaher Corp1.73%69,926$15M331
014WATWaters Corp1.72%35,379$15M282
015BIIBBiogen Inc1.72%67,902$15M324

Showing 1–15 of 62 holdings

RSPH Performance

Launched Nov 1, 2006

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

RSPH$12,906
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. RSPH $12,906. SPY $12,044. Use the arrow keys to read each point.$9,512$11,349$13,185Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for RSPH. Periods over one year show the average yearly return.
PeriodRSPH
Year to date+19.6%
1 month+5.2%
3 months+11.7%
1 year+29.1%
3 yearsper year+13.1%
5 yearsper year+6.1%
10 yearsper year+10.4%

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for RSPH
YearReturn barRSPH
2026 YTD+19.6%
2025+9.5%
2024−0.9%
2023+3.9%
2022−9.4%
2021+23.2%
2020+18.8%

RSPH in the news

RSPH Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 12, 2026.
0.59%Last 12 months
Payout per share
$0.22Last 12 months
Last payment
$0.05 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2017–2026

One bar per payment. 39 payments from 2017 to 2026 YTD. Mar 17, 2017 $0.02; Jun 16, 2017 $0.02; Sep 15, 2017 $0.03; Dec 15, 2017 $0.03; Mar 16, 2018 $0.02; Jun 15, 2018 $0.02; Sep 24, 2018 $0.03; Dec 24, 2018 $0.03; Mar 18, 2019 $0.03; Jun 24, 2019 $0.03; Sep 23, 2019 $0.03; Dec 23, 2019 $0.03; Mar 23, 2020 $0.03; Jun 22, 2020 $0.04; Sep 21, 2020 $0.03; Dec 21, 2020 $0.03; Mar 22, 2021 $0.03; Jun 21, 2021 $0.03; Sep 20, 2021 $0.04; Dec 20, 2021 $0.06; Mar 21, 2022 $0.05; Jun 21, 2022 $0.05; Sep 19, 2022 $0.04; Dec 19, 2022 $0.05; Mar 20, 2023 $0.05; Jun 20, 2023 $0.05; Sep 18, 2023 $0.05; Dec 18, 2023 $0.05; Mar 18, 2024 $0.05; Jun 24, 2024 $0.05; Sep 23, 2024 $0.05; Dec 23, 2024 $0.06; Mar 24, 2025 $0.06; Jun 23, 2025 $0.06; Sep 22, 2025 $0.06; Dec 22, 2025 $0.05; Mar 23, 2026 $0.06; Jun 22, 2026 $0.06; Sep 21, 2026 $0.05. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Sep 21, 2026Sep 25, 2026$0.05
Jun 22, 2026Jun 26, 2026$0.06
Mar 23, 2026Mar 27, 2026$0.06
Dec 22, 2025Dec 26, 2025$0.05
Sep 22, 2025Sep 26, 2025$0.06
Jun 23, 2025Jun 27, 2025$0.06
Mar 24, 2025Mar 28, 2025$0.06
Dec 23, 2024Dec 27, 2024$0.06
Sep 23, 2024Sep 27, 2024$0.05
Jun 24, 2024Jun 28, 2024$0.05
Mar 18, 2024Mar 22, 2024$0.05
Dec 18, 2023Dec 22, 2023$0.05

RSPH Risk

How much the fund’s monthly returns vary, scaled to a year.
15.7%
Annualised · 36 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.48
vs 3-month T-bills · to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−21.9%
Trough Sep 2022
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.78
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

RSPH Cost

Expense ratio0.40%
  • The middle half of Health Care (Broad) funds
  • Median 0.50%

10 of the 25 Health Care (Broad) funds charge less.

RSPH costs $40.00 a year on $10,000. The median Health Care (Broad) fund costs $50.00.

Other funds in Health Care (Broad)